Logo
Menu
  • Who We Are
  • How We Invest
  • Our Portfolio
    • Abzena
    • Ixlayer
    • Kiniciti
    • PathAI
  • Blog
  • Careers
  • Contact
Synbio 101: A primer on the next big life sciences technology

Synbio 101: A primer on the next big life sciences technology

by Biospring | Apr 25, 2022 | DNA, Drug Development, Drug Discovery, Manufacturing, Pharma, Supply Chain, Sybio, Synthetic Biology

Synthetic biology (synbio) is a life sciences technology that is transforming a broad range of industries including agriculture, chemicals, food, and medicine. Synbio applies engineering principles to biology and uses genomics to “code” organisms to yield a desired...
How Ginkgo Bioworks is using synthetic biology in the fight against COVID-19

How Ginkgo Bioworks is using synthetic biology in the fight against COVID-19

by Biospring | Apr 25, 2022 | Concentric, COVID-19, DNA, Ginkgo Bioworks, Jason Kelly, Synbio, Synthetic Biology

Ginkgo Bioworks is using its synthetic biology platform in the fight against the pandemic. We asked Jason Kelly, CEO of Ginkgo Bioworks, to update us on Concentric, a program that offers COVID-19 testing at scale to support schools and businesses in their reopening...

Recent Posts

  • Biospring Partners Welcomes Industry Executives To Its Advisory Board
  • Biomanufacturing: A Growing Field
  • Interview with Zach Weinberg
  • Driving Drug Development with Data Science
  • Proteomics 101

Recent Comments

No comments to show.

Newsletter

Thank you for subscribing!

Subscribe